NLM Digital Collections

Search

Start Over Collections Health Policy and Services Research ✖Remove constraint Collections: Health Policy and Services Research Subjects Opioid-Related Disorders -- drug therapy ✖Remove constraint Subjects: Opioid-Related Disorders -- drug therapy

11. Why health plans should go to the "MAT" in the fight against opioid addiction

Author(s):
Elitzer, Julia, author
Tatar, Margaret, author
Publication:
[Oakland, Calif.] : California Health Care Foundation, September 2017
Subject(s):
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Opioid-Related Disorders -- prevention & control
Buprenorphine -- therapeutic use
Comparative Effectiveness Research
Cost Savings
Drug Overdose -- drug therapy
Drug Overdose -- prevention & control
Health Care Costs
Health Services Accessibility
Healthcare Disparities
Inappropriate Prescribing -- prevention & control
Insurance Coverage -- legislation & jurisprudence
Managed Care Programs
Medicaid
Mental Health Services -- legislation & jurisprudence
Methadone -- therapeutic use
Naloxone
Naltrexone -- therapeutic use
Neonatal Abstinence Syndrome -- drug therapy
Opioid-Related Disorders -- epidemiology
Patient Care Management
Prescription Drug Diversion
State Government
Humans
California
United States

12. Overcoming data-sharing challenges in the opioid epidemic: integrating substance use disorder treatment in primary care

Publication:
[Oakland, Calif.] : California Health Care Foundation, July 2018
Subject(s):
Confidentiality
Opioid-Related Disorders -- therapy
Primary Health Care
Electronic Health Records -- legislation & jurisprudence
Informed Consent -- legislation & jurisprudence
Information Dissemination -- legislation & jurisprudence
Opioid-Related Disorders -- drug therapy
State Government
Humans
California
Connecticut
Oregon
United States
United States.

13. Early changes in waivered clinicians and utilization of buprenorphine for opioid use disorder after implementation of the 2021 HHS Buprenorphine Practice Guidelines

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, December 2, 2022
Subject(s):
Buprenorphine -- therapeutic use
Drug Prescriptions -- statistics & numerical data
Drug Utilization -- statistics & numerical data
Drug Utilization -- trends
Opioid-Related Disorders -- drug therapy
Practice Guidelines as Topic
Scope of Practice
United States
United States. Department of Health and Human Services.

15. Learning from COVID-19: how pandemic-era policies for methadone prescribing could improve opioid treatment

Author(s):
Suen, Leslie W., author
Nguyen, Oanh K., author
Knight, Kelly Ray, 1969- author
Publication:
[Oakland, California] : California Health Care Foundation, April 2022
Subject(s):
COVID-19
Methadone -- therapeutic use
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Drug Prescriptions
Health Policy
California

17. Opioid use disorder: barriers to Medicaid beneficiaries' access to treatment medications : report to Congressional committees

Publication:
Washington, DC : United States Government Accountability Office, January 2020
Subject(s):
Analgesics, Opioid -- supply & distribution
Analgesics, Opioid -- therapeutic use
Health Services Accessibility
Medicaid -- economics
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
United States
Centers for Medicare & Medicaid Services (U.S.)

18. Geographic disparities affect access to buprenorphine services for opioid use disorder

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, January 2020
Subject(s):
Buprenorphine -- supply & distribution
Health Services Accessibility
Medically Underserved Area
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
United States
United States. Department of Health and Human Services
United States. Substance Abuse and Mental Health Services Administration

19. Lowering the barriers to medication treatment for people with opioid use disorder: evidence for a low-threshold approach

Author(s):
Aronowitz, Shoshana V., author
Behrends, Czarina Navos, author
Lowenstein, Margaret, author
Schackman, Bruce, author
Weiner, Janet, author
Publication:
Philadelphia, PA : Leonard Davis Institute of Health Economics, January 2022
Subject(s):
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Health Services Accessibility
United States

20. Increasing access to medications for opioid use disorder: policy strategies during and after COVID-19 pandemic

Author(s):
Au-Yeung, Caroline M., author
Blewett, Lynn A., author
Winkelman, Tyler N.A., author
Publication:
New York, NY : Milbank Memorial Fund, October 2021
Subject(s):
Health Services Accessibility
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Buprenorphine -- therapeutic use
COVID-19
Health Policy
Methadone -- therapeutic use
Naltrexone -- therapeutic use
United States